Whittier Trust Co. Makes New $73,000 Investment in Omega Healthcare Investors, Inc. $OHI

Whittier Trust Co. purchased a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,000 shares of the real estate investment trust’s stock, valued at approximately $73,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in shares of Omega Healthcare Investors by 14.2% in the first quarter. GAMMA Investing LLC now owns 4,572 shares of the real estate investment trust’s stock worth $174,000 after purchasing an additional 568 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Omega Healthcare Investors by 5.0% in the first quarter. Janney Montgomery Scott LLC now owns 34,453 shares of the real estate investment trust’s stock worth $1,312,000 after purchasing an additional 1,651 shares during the last quarter. Oppenheimer Asset Management Inc. raised its stake in shares of Omega Healthcare Investors by 17.2% in the first quarter. Oppenheimer Asset Management Inc. now owns 31,736 shares of the real estate investment trust’s stock worth $1,209,000 after purchasing an additional 4,669 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Omega Healthcare Investors in the first quarter worth approximately $394,000. Finally, Cornerstone Enterprises LLC raised its stake in shares of Omega Healthcare Investors by 6.0% in the first quarter. Cornerstone Enterprises LLC now owns 135,830 shares of the real estate investment trust’s stock worth $5,172,000 after purchasing an additional 7,652 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

Shares of OHI opened at $40.48 on Friday. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $11.94 billion, a price-to-earnings ratio of 24.99, a PEG ratio of 1.90 and a beta of 0.70. The stock has a 50 day moving average of $41.59 and a 200 day moving average of $39.00. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors’s revenue was up 11.8% on a year-over-year basis. During the same period last year, the business posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on OHI shares. Mizuho increased their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, September 11th. Wells Fargo & Company increased their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock an “overweight” rating in a research note on Tuesday. Scotiabank increased their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research note on Thursday, August 28th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research report on Thursday, August 7th. Six equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Omega Healthcare Investors has an average rating of “Moderate Buy” and an average target price of $44.50.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.